A study by Dujardin et al. [69] showed that a key difference across AD cases of diverse clinical severity was a striking variability in tau spreading and seeding activity, hyperphosphorylation extent, and oligomerization state in postmortem tissue. The gene discussed is MAPT; the disease is Alzheimer disease.